1.26
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
107.18%
85.24
|
41.14 | 90.55 | 91.59 | 94.40 |
|
43.18%
39.92
|
70.25 | 59.05 | 65.96 | 69.42 |
Benefits Costs and Expenses |
38.75%
47.42
|
77.42 | 88.29 | 87.95 | 95.26 |
Costs And Expenses |
43.18%
39.92
|
70.25 | 59.05 | 65.96 | 69.42 |
Operating Income/Loss |
255.70%
45.32
|
-29.11 | 31.49 | 25.64 | 24.98 |
Nonoperating Income/Loss |
4.68%
-7.499
|
-7.164 | -7.496 | -8.267 | -6.101 |
Income/Loss From Continuing Operations Before Tax |
204.27%
37.82
|
-36.27 | 2.256 | 17.37 | 18.88 |
Income Tax Expense/Benefit |
1,177%
14.22
|
1.114 | 21.74 | 13.72 | 19.74 |
Income/Loss From Continuing Operations After Tax |
163.12%
23.60
|
-37.39 | 2.256 | 3.646 | -0.86 |
|
163.12%
23.60
|
-37.39 | 2.256 | 3.646 | -0.86 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.47%
161.72
|
160.97 | 0.273 | 159.71 | 159.01 |
Diluted Average Shares |
9.85%
176.84
|
160.97 | 1.274 | 160.23 | 159.01 |
Basic Earnings Per Share |
165.22%
0.15
|
-0.23 | 0.01 | 0.02 | -0.01 |
Diluted Earnings Per Share |
160.87%
0.14
|
-0.23 | 0.01 | 0.02 | -0.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):